Whole genome sequencing of live attenuated Leishmania donovani parasites reveals novel biomarkers of attenuation and enables product characterization
Abstract No licensed human vaccines are currently available against leishmaniasis. Several anti-leishmanial vaccines are currently undergoing testing, including genetically modified live-attenuated parasite vaccines. Studies with live attenuated Leishmania vaccines such as centrin deleted Leishmania...
Saved in:
Main Authors: | Sreenivas Gannavaram, John Torcivia, Lusine Gasparyan, Amit Kaul, Nevien Ismail, Vahan Simonyan, Hira L. Nakhasi |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/d976c0ed5ec047e4a8b50c73f5058f1b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing
by: Wen-Wei Zhang, et al.
Published: (2020) -
Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis
by: Subir Karmakar, et al.
Published: (2021) -
Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice
by: Guilherme D. Melo, et al.
Published: (2017) -
Identification of a secreted casein kinase 1 in Leishmania donovani: effect of protein over expression on parasite growth and virulence.
by: Mary Dan-Goor, et al.
Published: (2013) -
Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis.
by: Doumet Georges Helou, et al.
Published: (2021)